Skip to main content
. 2022 Aug 8;8(5):224–230. doi: 10.1016/j.aace.2022.07.004

Table 2.

Previous Reports of HNF1A-Associated Neonatal Hypoglycemia or Congenital Hyperinsulinism

Publication citation Variant(s) reported ClinVar variant classification (for MODY)a Duration of hypoglycemia (or age at which diazoxide was discontinued) Presence of macrosomia or LGA birth weight Report of MODY within the same individual, age at diagnosis
Brusgaard et al,3Endocr Abstr 2006 (abstract only) 1. c.476G>A, p.Arg159Gln 1. Pathogenic 1. 3 y 1. Yes, 4378 g 1. Unclear
Pearson et al2, PLoS Med 2007 1. Mutation not reported 1. Unknown 1. <48 h 1. Not reported 1. Not reported
Stanescu et al,4J Clin Endocrinol Metab 2012 1. c.94G>T, p.Glu32X
2. c.871C>T, p.Pro291Ser
1. Pathogenic
2. Likely benign
1. 6 y
2. 36-42 mo
1. Yes, 93rd percentile
2. No, 7th percentile
1. Not reported
2. Not reported
Snider et al,21J Clin Endocrinol Metabol 2013 1. c.94G>T, p.Glu32∗ (previously included in the study by Stanescu et al4, case 1)
2. c.871C>T, p.Pro291Ser (previously included in the study by Stanescu et al4, case 2)
3. c.1541A>G, p.His514Arg
1. Pathogenic (duplicate)
2. Pathogenic (duplicate)
3. VUS vs benign
1. Not reported
2. Not reported
3. Not reported
1. Not reported
2. Not reported
3. Not reported
1. Not reported
2. Not reported
3. Not reported
Tung et al,5Pediatr Diabetes 2018 1. C.94G>T, p.Glu32 (previously included in the studies by Stanescu et al4 and Snider et al21, case 1)
2. c.871C>T, p.Pro291Ser (previously included in the studies by Stanescu et al4 and Snider et al21, case 2)
3. c.872dupC, p.Pro291fs
4. c.654T>A, p.Tyr218
5. c.654T>A, p.Tyr218
6. c.872dupC, p.Pro291fs
7. c.872delC, p.Pro291fs
1. Pathogenic (duplicate)
2. Benign
3. Pathogenic
4. Not classified
5. Not classified
6. Pathogenic
7. Pathogenic
1. 6.8 y
2. 3.5 y
3. Continued on diazoxide at time of publication
4. 7.3 y
5. Continued on diazoxide at time of publication
6. Continued on diazoxide at time of publication
7. Continued on diazoxide at time of publication
1. Yes, 4167g, 92nd percentile
2. No, 7th percentile
3. No, 71st percentile
4. Not reported
5. No, 44th percentile
6. No, 84th percentile
7. Yes, 97th percentile
“At the time of analysis, the median age of the children in this cohort was 7.0 years (IQR = 2.3-13.5 years)… screening tests for diabetes [were performed] after age 10 and none of them had developed diabetes mellitus at the time of analysis.”
Dusatkova et al,6J Pediatric Endocrinol Metabol 2011 1. c.815G>A, p.Arg272His 4. Pathogenic/likely pathogenic 1. “At least 1 attack of symptomatic hypoglycemia in childhood” at the age of 9 y in the setting of fasting; experienced tonic-clonic convulsions repeatedly in childhood without blood glucose check but semiquantitative estimations of urine ketone bodies were positive (grades 3-4) 1. Yes, 4750 g (+1.99 SD) 1. Yes, age 19 y
Rozenkova et al,19J Clin Endocrinol Metabol 2015 1. p.Gly31Asp
2. p.Asn62∗
3. p.Leu254Gln
4. p.Arg272His (previously included in the study by Dusatkova et al6)
5. p.Glu508Lys
1. Benign
2. VUS
3. Not classified
4. Pathogenic/likely pathogenic (duplicate)
5. VUS vs likely benign
1. Continued on diazoxide at time of publication, age of 6 y
2. Resolved in “infancy”
3. Resolved in “infancy”
4. Resolved in “childhood”
5. Continued on diazoxide at time of publication, age of 4 y
1. No
2. Yes
3. Yes
4. Yes
5. No
1. Not reported
2. Not reported
3. Not reported
4. Not reported
5. Not reported
Yau et al,7Eur J Med Genet 2020 1. c.-230_-101del
2. c.713G>T, p.Arg238Met
1. Not classified
2. Not classified
1. Continued on diazoxide at time of publication, age of “almost 6 y”
2. Continued on diazoxide at time of publication, age of 5 y
1. No, 4065 (+1.7 SD)
2. No, 4260 g (+1.7 SD)
1. No
2. No
Cromer et al, 2022 (infants) 1. c.811C>T, p.Arg271Trp
2. c.326+1G>T
3. c.794A>G, p.Tyr265Cys
1. Pathogenic
2. Pathogenic
3. VUS
1. Continued on diazoxide at time of publication, age of 1 y
2. 1 mo
3. Continued on diazoxide at time of publication, age of 2 y
1. Yes, 4380 g (>99th percentile)
2. Yes, 3900 g (>99th percentile)
3. Yes, 5810 g (>99th percentile)
1. No
2. No
3. No

Abbreviations: LGA = large for gestational age; MODY = maturity-onset diabetes of the young; VUS = variant of uncertain significance.

Unique reports of cases with pathogenic or likely pathogenic variants are shown in bold

a

Variant classification obtained from ClinVar database, June 29, 2022.35 All variant classifications were based on clinical laboratory submissions and/or expert panel review after the publication of the 2015 American College of Medical Genetics variant classification criteria.22